242 related articles for article (PubMed ID: 6548545)
1. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
Duax WL; Swenson DC; Strong PD; Korach KS; McLachlan J; Metzler M
Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor stereochemistry: ligand binding orientation and influence on biological activity.
Chae K; Gibson MK; Korach KS
Mol Pharmacol; 1991 Nov; 40(5):806-11. PubMed ID: 1944245
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
[TBL] [Abstract][Full Text] [Related]
4. Diethylstilbestrol metabolites and analogs: differential ligand effects on estrogen receptor interactions with nuclear matrix sites.
Metzger DA; Curtis S; Korach KS
Endocrinology; 1991 Apr; 128(4):1785-91. PubMed ID: 2004602
[TBL] [Abstract][Full Text] [Related]
5. Molecular conformation, receptor binding, and hormone action of natural and synthetic estrogens and antiestrogens.
Duax WL; Griffin JF; Weeks CM; Korach KS
Environ Health Perspect; 1985 Sep; 61():111-21. PubMed ID: 3905370
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes.
Korach KS; Sarver P; Chae K; McLachlan JA; McKinney JD
Mol Pharmacol; 1988 Jan; 33(1):120-6. PubMed ID: 3122017
[TBL] [Abstract][Full Text] [Related]
7. Simulation of the different biological activities of diethylstilbestrol (DES) on estrogen receptor alpha and estrogen-related receptor gamma.
Nam K; Marshall P; Wolf RM; Cornell W
Biopolymers; 2003 Jan; 68(1):130-8. PubMed ID: 12579585
[TBL] [Abstract][Full Text] [Related]
8. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
[TBL] [Abstract][Full Text] [Related]
9. Estrogenic activity in vivo and in vitro of some diethylstilbestrol metabolites and analogs.
Korach KS; Metzler M; McLachlan JA
Proc Natl Acad Sci U S A; 1978 Jan; 75(1):468-71. PubMed ID: 272664
[TBL] [Abstract][Full Text] [Related]
10. Steroid receptor forms and their interaction with cytoplasmic modulators.
Sato B; Nishizawa Y; Maeda Y; Noma K; Honma T; Matsumoto K
J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866
[TBL] [Abstract][Full Text] [Related]
11. Diethylstilbestrol metabolites and analogs. Stereochemical probes for the estrogen receptor binding site.
Korach KS; Chae K; Levy LA; Duax WL; Sarver PJ
J Biol Chem; 1989 Apr; 264(10):5642-7. PubMed ID: 2925625
[TBL] [Abstract][Full Text] [Related]
12. Multiple estrogen binding sites in the uterus: stereochemistry of receptor and non-receptor binding of diethylstilbestrol and its metabolites.
Chae K; Johnston SH; Korach KS
J Steroid Biochem Mol Biol; 1991 Jan; 38(1):35-42. PubMed ID: 1997122
[TBL] [Abstract][Full Text] [Related]
13. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
[TBL] [Abstract][Full Text] [Related]
14. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
15. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.
Wiese TE; Polin LA; Palomino E; Brooks SC
J Med Chem; 1997 Oct; 40(22):3659-69. PubMed ID: 9357533
[TBL] [Abstract][Full Text] [Related]
16. Binding characteristics of dialkyl phthalates for the estrogen receptor.
Nakai M; Tabira Y; Asai D; Yakabe Y; Shimyozu T; Noguchi M; Takatsuki M; Shimohigashi Y
Biochem Biophys Res Commun; 1999 Jan; 254(2):311-4. PubMed ID: 9918834
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional quantitative structure-activity relationship study of nonsteroidal estrogen receptor ligands using the comparative molecular field analysis/cross-validated r2-guided region selection approach.
Sadler BR; Cho SJ; Ishaq KS; Chae K; Korach KS
J Med Chem; 1998 Jun; 41(13):2261-7. PubMed ID: 9632359
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of 17alpha-20E-21-(4-substituted phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as probes for the estrogen receptor alpha hormone binding domain.
Hanson RN; Lee CY; Friel CJ; Dilis R; Hughes A; DeSombre ER
J Med Chem; 2003 Jul; 46(14):2865-76. PubMed ID: 12825929
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional model of nonsteroidal estrogen receptor ligand binding/electron topological method.
Guzel Y; Sivritas K
Arzneimittelforschung; 2004; 54(6):348-54. PubMed ID: 15281621
[TBL] [Abstract][Full Text] [Related]
20. Novel estrogen receptor ligands based on an anthranylaldoxime structure: role of the phenol-type pseudocycle in the binding process.
Minutolo F; Antonello M; Bertini S; Ortore G; Placanica G; Rapposelli S; Sheng S; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Macchia M
J Med Chem; 2003 Sep; 46(19):4032-42. PubMed ID: 12954056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
